Literature DB >> 26159289

Simultaneous deletion of NOD1 and NOD2 inhibits in vitro alloresponses but does not prevent allograft rejection.

Sashi G Kasimsetty1, Andrew T Scheinok1, Alana A Shigeoka1, Dianne B McKay2.   

Abstract

Pattern recognition receptors (PRRs) play an important role in host anti-donor responses to transplanted tissue. A key trigger of the host alloresponse involves recognition of foreign antigen presented on activated antigen presenting cells by the host T cells. Emerging data suggest that PRR blockade can abrogate host anti-donor responses by interfering with activation of antigen presenting cells, particularly activation of dendritic cells. Our study asked whether blockade of a well-characterized family of intracellular PRRs, the NOD family, interfered with alloantigen recognition and allograft rejection. We found that deletion of either NOD1 or NOD2 in antigen presenting cells (APCs) had no effect on induction of T cell proliferation to alloantigen, but that simultaneous deletion of NOD1 and NOD2 significantly inhibited T cell responses. There was however no effect of the NOD deletion on skin graft rejection when NOD1×NOD2 skin was transplanted onto allogeneic hosts or when WT skin was transplanted onto NOD1×NOD2 deficient recipients. The conclusion of this study is that in vitro alloresponses are negatively impacted by the simultaneous deletion of NOD1 and NOD2, but that allograft rejection across a stringent allo barrier is not affected. Our results suggest that the NOD family members, NOD1 and NOD2, play a collaborative role in T cell activation by alloantigen and that their blockade in vitro can inhibit T cell responses.
Copyright © 2015 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Allograft rejection; Alloresponses; Innate immunity; NOD1; NOD2; Pattern recognition receptors

Mesh:

Substances:

Year:  2015        PMID: 26159289      PMCID: PMC4558238          DOI: 10.1016/j.imbio.2015.06.011

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  23 in total

1.  Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue.

Authors:  F G Lakkis; A Arakelov; B T Konieczny; Y Inoue
Journal:  Nat Med       Date:  2000-06       Impact factor: 53.440

2.  The frameshift mutation in Nod2 results in unresponsiveness not only to Nod2- but also Nod1-activating peptidoglycan agonists.

Authors:  Mihai G Netea; Gerben Ferwerda; Dirk J de Jong; Catherine Werts; Ivo G Boneca; Muguette Jéhanno; Jos W M Van Der Meer; Dominique Mengin-Lecreulx; Philippe J Sansonetti; Dana J Philpott; Sébastien Dharancy; Stephen E Girardin
Journal:  J Biol Chem       Date:  2005-08-22       Impact factor: 5.157

Review 3.  Nod-like proteins in immunity, inflammation and disease.

Authors:  Jörg H Fritz; Richard L Ferrero; Dana J Philpott; Stephen E Girardin
Journal:  Nat Immunol       Date:  2006-12       Impact factor: 25.606

4.  Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity.

Authors:  Jörg H Fritz; Lionel Le Bourhis; Gernot Sellge; Joao Gamelas Magalhaes; Hafida Fsihi; Thomas A Kufer; Cathy Collins; Jérôme Viala; Richard L Ferrero; Stephen E Girardin; Dana J Philpott
Journal:  Immunity       Date:  2007-04-12       Impact factor: 31.745

Review 5.  Dendritic cells in the kidney.

Authors:  Rohan John; Peter J Nelson
Journal:  J Am Soc Nephrol       Date:  2007-09-05       Impact factor: 10.121

6.  Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination.

Authors:  Ernst Holler; Gerhard Rogler; Julia Brenmoehl; Joachim Hahn; Hans Herfarth; Hildegard Greinix; Anne M Dickinson; Gerard Socié; Daniel Wolff; Gottfried Fischer; Graham Jackson; Vanderson Rocha; Beate Steiner; Guenther Eissner; Jeorg Marienhagen; Juergen Schoelmerich; Reinhard Andreesen
Journal:  Blood       Date:  2006-01-19       Impact factor: 22.113

7.  Nucleotide oligomerization and binding domain 2-dependent dendritic cell activation is necessary for innate immunity and optimal CD8+ T Cell responses to influenza A virus infection.

Authors:  Christopher Lupfer; Paul G Thomas; Thirumala-Devi Kanneganti
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

8.  Activation of nucleotide oligomerization domain 2 exacerbates a murine model of proteoglycan-induced arthritis.

Authors:  H L Rosenzweig; M M Jann; T T Glant; T M Martin; S R Planck; W van Eden; P J S van Kooten; R A Flavell; K S Kobayashi; J T Rosenbaum; M P Davey
Journal:  J Leukoc Biol       Date:  2009-01-07       Impact factor: 4.962

9.  The role of afferent lymphatics in the rejection of skin homografts.

Authors:  C F Barker; R E Billingham
Journal:  J Exp Med       Date:  1968-07-01       Impact factor: 14.307

Review 10.  Licensing Adaptive Immunity by NOD-Like Receptors.

Authors:  Dong Liu; Anne Marie Rhebergen; Stephanie C Eisenbarth
Journal:  Front Immunol       Date:  2013-12-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.